Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
about
Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivoAntithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activationIn vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitorComputationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesSynthesis of thrombin-inhibiting heparin mimetics without side effects.Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.Nitrophorin 2, a factor IX(a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasisCarboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.Novel inhibitors of factor X for use in cardiovascular diseases.Choice of agents to limit the coagulation cascade in acute coronary syndromes.New antithrombin-based anticoagulants.Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide.Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026.Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom.Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.The antithrombotic and haemostatic effects of LASSBio-752: a synthetic, orally active compound in an arterial and venous thrombosis model in rats.Is the antithrombotic effect of sulfated galactans independent of serpin?In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata).Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade.
P2860
Q22001540-77A85D83-3CFC-49C9-A7CD-E20D5F952F97Q24546028-06420EF7-D283-4D3A-8F80-EC86CFD1838DQ28238054-B304C88A-162A-463F-8FB4-5599E2A9BB0BQ28469258-4ACF305A-2237-49B0-BA95-D97E39E2B66AQ30573078-91C4431A-766D-4737-B771-5412BA408D8DQ33331831-D8171456-3339-4EF6-BA25-B50B8F94C9FCQ33691654-FF25F99D-4097-446E-BF47-A2887524AC8BQ33696717-B40EB056-E79C-435D-80B6-1BE22584EFFBQ33748076-672D77F4-9F05-407E-A1C7-6D2BAF023738Q34027530-C4C9F3A5-B13E-4FFA-8084-191BF1C8A5BAQ34674164-D87170DF-0508-4C60-B8D9-53BD1F8F7725Q35620257-9E1FD320-C541-43D7-B14A-242D482ADBB2Q38331843-8E84FE36-1487-420E-BD4F-3FC652B54B40Q38353159-D9F45FD1-CBBE-4CF7-950D-BC2F64F12937Q38354364-B93D16CE-B2B2-4669-930E-87860FA58C32Q38758227-783F97D0-8851-48BC-8FC2-6419E70B569DQ42970671-CB42D5C4-D761-49D6-B8C5-C53F1FBDE4F9Q44854415-383E8FE3-FE62-4B35-8BD8-F8D82A7430E1Q44893876-78157A2E-187D-4749-98E9-0CDC9208296AQ48104079-0E533487-F52E-4F66-8D23-6DAD3FA693C0Q50483208-8AE688A3-0B46-4D2E-919D-57D4DFBD4333Q50642026-C21E6D50-E932-493B-A367-15DA4CA0B437Q55098431-6481C3FB-1B1A-471E-BA5B-3CB17D93390F
P2860
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Biochemical and pharmacologica ...... G 31540) and standard heparin.
@en
type
label
Biochemical and pharmacologica ...... G 31540) and standard heparin.
@en
prefLabel
Biochemical and pharmacologica ...... G 31540) and standard heparin.
@en
P2093
P356
P1433
P1476
Biochemical and pharmacologica ...... G 31540) and standard heparin.
@en
P2093
Herbert JM
Hérault JP
Lormeau JC
Meuleman DG
van Amsterdam RG
P304
P356
10.1161/01.RES.79.3.590
P577
1996-09-01T00:00:00Z